Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 08 Mar 2023
As diabetes pills become popular in the media as a quick fix for weight loss, experts warn that there is simply no magic pill when it comes to weight loss, but this paper may be reused, resulting in double weight. TO DO.
Read Full NewsThe U.S. Food and Drug Administration on Thursday authorized the emergency use of a generic over-the-counter tablet to treat infestations caused by the New World screwworm...
Extent of lymph node dissection, defining high-risk criteria, oral androgen deprivation therapy (ADT), and darolutamide plus ADT are among the highlights for prostate cancer management from AUA 2026.
A novel PET imaging agent identified AD-related tau earlier and in more patients than the currently used tracer, possibly speeding AD detection, a new study shows.
A Kaiser Permanente study shows some people who initially struggle with CPAP adherence still use the device at 1 year, suggesting CMS’ 90-day cutoff is too strict.
Even though the real-world patients in a phase 4 study were older and heavier, ublituximab provided safety and tolerability at least comparable to that in 2 pivotal trials.
Organon said on Wednesday the U.S. Food and Drug Administration has approved the expanded use of its arthritis drug, a biosimilar to Roche's Actemra, to treat a...
Three laboratories in Democratic Republic of Congo have run out of supplies to test for Ebola, the World Health Organization said, as the outbreak of the dangerous...
1.
A Win for AI in Cancer; 2025's Transformative Drugs; FDA Clarifies 'Underway' Trials
2.
It has been discovered that personalized dosing in the treatment of prostate cancer improves patient outcomes.
3.
Potential new therapy for childhood brain cancer could heal treatment-resistant tumors
4.
Ivonescimab Tops Pembrolizumab in PD-L1-Positive, Advanced NSCLC
5.
For some patients with bladder cancer that has invaded the muscle, trimodality therapy is just as effective as radical cystectomy.
1.
Acrochordon: What It Is, Causes, And How To Manage This Skin Condition
2.
Uncovering the Reality of Colon Cancer: A Look at Real Images
3.
Evolution of Cancer Care Through Developmental Therapeutics
4.
Reshaping the Battlefield Through Tumor Microenvironment Modulation for Cancer Therapy
5.
Demystifying Hypereosinophilic Syndrome: Symptoms, Diagnosis, and Treatment Options
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
International Lung Cancer Congress®
1.
From Relapse to Remission : Chasing the Invisible and Redefining Long-Term Survival in Adult R/R B-Cell ALL
2.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part I
3.
Navigating the Complexities of Ph Negative ALL - Part XIII
4.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases - Part II
5.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- Summarization of the New Perspective
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge